Explain Why Semglee Will Be "Interchangeable" With Lantus

Semglee (insulin glargine-yfgn U-100) will be the first "interchangeable" biosimilar.

It was originally approved as a new brand of insulin glargine, not a Lantus generic...and switching required a new Rx. Now that's changing.

Be ready to explain what an "interchangeable" biosimilar is.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote